FDA Approves REYATAZ® (atazanavir Sulfate) 300 Mg Single Capsule Formulation In Combination Therapy For Adults With (Medical News Today) at Regulatory Affairs Syndicator

FDA Approves REYATAZ® (atazanavir Sulfate) 300 Mg Single Capsule Formulation In Combination Therapy For Adults With (Medical News Today)

Published by Yahoo! News Search Results for Food and Drug Admin October 23rd, 2006 in Yahoo FDA News, Regulatory Affairs

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a new 300 mg single capsule formulation of REYATAZ® (atazanavir sulfate) for the treatment of HIV-1 infection in adults as part of combination therapy. [click link for full article]